INS and metabolic dysfunction-associated steatotic liver disease: For example, supplementation with dihydromyricetin, a flavonoid structurally related to myricetin, at a dose of 600 mg/d in patients with non-alcoholic fatty liver disease (NAFLD) resulted in significant improvements in glucose and lipid metabolism, along with enhanced insulin sensitivity [19].